project id: TCGA-HNSC; case submitter id: TCGA-CV-7422; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 8.4; age at index: 60; days to birth: -22098; days to death: 1037; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1937; year of death: 1999; age at diagnosis: 22098; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic n: N1; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 1997; alcohol history: Yes; cigarettes per day: 4.383561643835616; pack years smoked: 80.0; years smoked: 40.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.5; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-CV-7422-01A-21; percent lymphocyte infiltration: 25.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;